Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $4.98B.
ENTERPRISE VALUE (EV)
$4.98B
Adaptive Biotechnologies Corporation
Market Cap
$4.84B
Enterprise Value (EV)
$4.98B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Adaptive Biotechnologies Corporation (ADPT) | $4.84B | $4.98B |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.81B | $4.19B |
| LifeStance Health Group, Inc. (LFST)vs › | $4.74B | $4.71B |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.92B | $4.82B |
| BillionToOne, Inc. (BLLN)vs › | $5.02B | $4.61B |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.50B | $4.50B |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.49B | $4.78B |
| Erasca, Inc. (ERAS)vs › | $5.11B | $5.11B |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.20B | $4.97B |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.20B | $5.57B |
Market Cap
$4.84B
Total Debt
$210.36M
Cash
$70.50M
Enterprise Value
$4.98B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
